99¦~02¤ë¸¹ ¹D ªk ªk °T (214)

DEEP & FAR

 

 

«IÅv®×¯A¤Î¤ºÁô¹w´Á°ÝÃD

¤G¡BAstra Aktiebolag v. Andrx Pharm., Inc.(12)

 

³¯ºaºÖ ±M§Q¥N²z¤H

¡E¤¤°êÂåÃľǰ|ÃľǨt¾Ç¤h

¡E¤é¥»ºÖ©£¤j¾Ç¥ÍÃľǩҺӤh

¡E¶§©ú¤j¾ÇÂå¾ÇÃIJz©Ò³Õ¤h

 

 

µM¦Ó¸Ó¸ÑÄÀ¡AµLªk«P¨Ï²ßª¾§Þ³N¨ã¥i±M§Q©Ê¡C¦b1993¦~©M1994 ¦~¡ACKD ¥æ¥I¤©KIPO »PAstra¤§¦¨¥÷¤Î¨óij¡A¥²¾É­P¦b­ì³B§Î¦¨¤ÀÂ÷¼h¡C¦]¦Ó¼f§Pªk®x¥¿½T¦a»{©w¤ºÁô¹w´Á¡C

                                                                 IV            

'281 ±M§Q¤§¥Ó½Ð±M§Q½d³ò²Ä9¶µ«Y¨Ìªþ©ó²Ä1¶µ¡A©ó¥Ó½Ð±M§Q½d³ò²Ä9 ¶µ¤§½Ð¨D¤º®e¡AARC¬°ÁC»Ä¡BºÒ»Ä¡A©Îª¿»Ä¤§ÆP©ÊÆQ¡CÁp¨¹¦a¤èªk°|µo²{¡Aų©óCKD ¤§±M§Q¥Ó½Ð®×¡A¤@¯ë¼ô±x¸Ó¶µ§ÞÃÀ¤H¤h¡A±N²Ä'281 ±M§Q¥Ó½Ð±M§Q½d³ò²Ä9¶µ¤§©Ò½Ð¨DÆP©ÊÆQ¡A¥Ñ«YCKD ¥Ó½Ð®×©Ò´¦ÅSºëÓi»Ä¤©¥H´À¥N¡A¤DÅã¦Ó©öª¾¡C´«¨¥¤§¡AÁp¨¹¦a¤èªk°|»{¬°¡A¥H¤@ARC¨ú¥N¥t¤@ARC«YÅãµM©öª¾[1]¡C¨Ì¾Ú35 U.S.C.¡± 103 ¤§Åã¦Ó©öª¾«Y®Ú¾Ú¨Æ¹ê¨M©w¤§ªk«ßµ²½×[2]¡C

CKD's ±M§Q¥Ó½Ð®×¥H§t®ò°ò»Ä©Îomeprazole ÆP©ÊÆQ¤§®Ö¤ß¥]½¤§@¬°"°ò¥»³¡¥÷" ©Î"ÆP¤ÏÀ³¤§²Õ¦¨¥÷"[3]¡CÁp¨¹¦a¤èªk°|(»PÁú°ê¤W¶Dªk®x) µo²{CKD ¥Ó½Ð®×¦C¥XºëÓi»Ä§@¬°®Ö¤ß¤§"°ò¥»³¡¥÷"¡A¥B¥i¿ï¾Ü¥HL-ºëÓi»Ä§@¬°"ÆP©Êª«½è"[4]¡C¦bÁú°ê¤W¶Dªk®x¤§«e¡AAstra ©Ó»{¡A"L ºëÓi»Ä¤@¯ë¤wª¾§@¬°ÆP©Ê¤ÏÀ³¤§¤Æ¦Xª«"[5]¡CAstra ¨Ã¥B»{ª¾¡A¨ä¤w±M§Q¤§µo©ú"¦b¤èªkA¤¤¡AL-ºëÓi»Ä«Y©ö©ó¬°ÆP©Ê¤ÏÀ³¤§¤Æ¦Xª«©Ò´À¥N"[6]¡C

¬ö¿ýÅã¥ÜBanakar ³Õ¤hÃÒ¹ê¡A¼ô±x»s¾¯³B¤è§ÞÃÀ¤H¤h¡AÅãµM©ö©ó¥HÁC»Ä¡BºÒ»Ä©Îª¿»Ä¤§ÆP©ÊÆQ´À´«¦bCKD ¥Ó½Ð®×¤¤¤§ºëÓi»Ä¡C¦pBanakar ³Õ¤h©Ò­z¡A©Ò¦³³o¨Çª«½è¬Ò«Y¥ií©womeprazole ¤§ARC[7]¡C

 

  



[1] Omeprazole III, slip op. at 35.

[2] Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157, 1164 (Fed. Cir. 2006)

[3] Id.

[4] Id. at 35; (Korean) Appellate Trial Court Decision at 3, In Re Omeprazole Patent Litig., Appeal Nos. 04-1562, 04-1563, 04-1589 (Fed. Cir. Aug. 13, 2004).

[5] Id., Astra¡¦s Supplement of the Reasons for the Request for Appeal (to Korean Appellate Court),Astra ¤§¸É¥R¤W¶D²z¥Ñ (¹ïÁú°ê¤W¶Dªk®x) at 8.

[6] Id. at 7-8.

[7] Omeprazole III, slip op. at 36.